home
portfolio
approach
team
careers
news
contact
investor portal
home
portfolio
approach
team
careers
news
contact
investor portal
Nextech Invest
Turning Point Therapeutics to Participate in Goldman Sachs 42nd Annual Healthcare Conference
Turning Point Therapeutics to Participate in Goldman Sachs 42nd Annual Healthcare Conference
Post navigation
Previous Post
Previous
Primary Endpoint Met in Phase 3 Study of the Anti-PD-L1 Antibody Sugemalimab in Stage III Non-Small Cell Lung Cancer
Next Post
Next
Silverback Therapeutics to Participate in the Goldman Sachs 42nd Annual Global Healthcare Conference